3Gopinath B, Harris DC,Wall JR, et al. Relationship between thyroid dys- function and chronic kidney disease in community-dwelling older adults[J]. Maturitas, 2013,75 (2) : 159-164.
4Hataya Y, Igarashi S, Yamashita T, et al. Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of re- nal function in chronic kidney disease patients[J]. Clin Exp Nephrol,2013, 17(4) :525-531.
8Chade AR,Rodriguez-Porcel M ,Grande JP,et al. Distinct renal injury in early atherosclerosis and renovascular disease[J]. Circulation, 2002,106 (9) : 1165-1171.
10Attia DM, Feron O, Goldschmeding R, et al. cholesterolemia in rats in- duces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism[J]. J Am SocNephro1,2004,15 (4) :949-957.
4Vargas F, Moreno JM, Rodrtguez - Gomez I, et al. Vascular and renal function in experimental thyroid disorders [J]. Eur J Endocrinol, 2006, 154(2) :197 -212.
5Takeda T, Mequistant T, Orland RA, et al. Loss of glomerular foot process is associated with uncoupling of podocalyxin frome the action toskeleton [ J ]. J Clin Invest, 2001, 108(2) :289 -301.
7Xie Y, Nishi S, Iguchi S, et al. Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process[J].Kidney Int,2001,59:959-974
8Yu XQ, Wu LL, Huang XR, et al. Osteopontin expression in progressive renal injury in remnant kidney role of angiotensin II[J].Kidney Int,2000,58:1469-1480
9Panzer U,Thaiss F,Iahner G,et al.Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis[J].Kidney Int,2001,59:1762-1769
10Okada H,Moriwaki K,Kauuri R,et al.Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats[J].Am J Physiol,2000,F278:110-112
5Gopinath B, Harris DC, Wall JR, et al. Relationshipbetween thyroid dysfunction and chronic kidney disease incommunity-dwelling older adults[J].Maturitas, 2013,75(2): 159-164.
6Levey Andrew S, Eckardt Kai-Uwe, Tsukamoto Yusuke, etal.Definition and classification of chronic kidney disease: a positionstatement from Kidney Disease: Improving Global Outcomes(KDIGO)[J].Kidney International, 2005,67 ( 6): 2089-2100.
7Palmer Biff F.Proteinuria as a therapeutic target in patientswith chronic kidney disease[J].American Journal ofNephrology, 2007,27 (3): 287-293.
8Mishra J, Ma Q, Prada A,et al.Identification of neutrophilgelatinase-associated lipocalin as a novel early urinarybiomarker for ischemic renal injury[J].J Am Soc Nephrol,2003,14 ( 10): 2534.
